Vaccine against mumps containing a Jeryl-Lynn virus strain

US6024962A · kind A · utility

Assignee

• SmithKline Beecham Biologicals S.A. · BE

Inventors

• Nigel Harford · Overijse, BE
• Brigitte Desiree Alberte Colau · Genval, BE
• Jean Didelez · Court-Saint-Etienne, BE

Key dates

• Filing date: May 13, 1996
• Grant date: Feb 15, 2000
• Expiry date: May 13, 2016

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and antibody titres than known commercial vaccines.